PVR

An Experimental Proliferative Vitreoretinopathy (PVR) Model
in Pigmented Rabbits for Testing of New Treatment

 

The proliferative vitreoretinopathy (PVR) model was successfully induced and demonstrated 28 days after one injection of rabbit conjunctival fibroblast cells (RCFs). The PVR model is able to test the efficacy of the test articles to discover new treatments for patients with PVR.

 

"Toxikon is results-oriented and adherence to the Quality and Regulatory systems directives"

Henry Gonzalez
Henry Gonzalez
Compliance Officer